Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows – operating activities:
Net loss	$ (5,982)	$ (7,968)
Non-cash items –
Share-based plans expense	343	310
Treasury shares issued for 401(k) contributions	1,173	1,315
Depreciation and amortization	1,417	1,327
Investment/asset impairment charges, net	32	48
Gain on dispositions, net	(63)	(5)
777X and 767 reach-forward losses	5,140	3,006
Other charges and credits, net	217	270
Changes in assets and liabilities –
Accounts receivable	(836)	(275)
Unbilled receivables	(679)	(1,042)
Advances and progress billings	(2,065)	1,666
Inventories	(116)	(6,854)
Other current assets	227	(26)
Accounts payable	539	122
Accrued liabilities	574	327
Income taxes receivable, payable and deferred	93	(282)
Other long-term liabilities	(294)	(228)
Pension and other postretirement plans	(436)	(736)
Financing receivables and operating lease equipment, net	274	258
Other	176	137
Net cash used by operating activities	(266)	(8,630)
Cash flows – investing activities:
Payments to acquire property, plant and equipment	(1,986)	(1,582)
Proceeds from disposals of property, plant and equipment	5	46
Acquisitions, net of cash acquired		(50)
Proceeds from dispositions	35
Contributions to investments	(36,337)	(1,751)
Proceeds from investments	32,674	4,546
Supplier notes receivable	(292)	(494)
Repayments on supplier notes receivable		40
Purchase of distribution rights		(88)
Other		(14)
Net cash (used)/provided by investing activities	(5,901)	653
Cash flows – financing activities:
New borrowings	138	10,120
Debt repayments	(721)	(4,824)
Employee taxes on certain share-based payment arrangements	(28)	(73)
Dividends paid on mandatory convertible preferred stock	(244)
Other	43	15
Net cash (used)/provided by financing activities	(812)	5,238
Effect of exchange rate changes on cash and cash equivalents	39	8
Net decrease in cash & cash equivalents, including restricted	(6,940)	(2,731)
Cash & cash equivalents, including restricted, at beginning of year	13,822	12,713
Cash & cash equivalents, including restricted, at end of period	6,882	9,982
Less restricted cash & cash equivalents, included in Investments	709	21
Cash and cash equivalents at end of period	$ 6,173	$ 9,961